LAKE STREET ADVISORS GROUP, LLC - BROOKLYN IMMUNOTHERAPEUTICS ownership

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 39 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LAKE STREET ADVISORS GROUP, LLC ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2022$604,0002,446,4170.04%
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q3 2022
NameSharesValueWeighting ↓
AJ WEALTH STRATEGIES, LLC 36,001$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders